Receives Marketing Authorization

Related by string. * RECEIVES . receives . RECEIVE . re ceive : RECEIVE AN E MAIL . Iron Consulting receives . Parents Receive Graphic . Receive mediabistro.com s / marketing . markets . market : MARKET WIRE via COMTEX . RBC Capital Markets . Stock Market / Authorizations . authorizations . AUTHORIZATION : share repurchase authorization . submitted Marketing Authorization . repurchase authorization * *

Related by context. Frequent words. (Click for all words.) 77 Positive Opinion 72 Marketing Authorization 72 FDA Accepts 71 Phase III Clinical Trial 70 CE Marked 69 Drug Candidate 69 Patent Covering 68 Phase III Trial 68 Orphan Medicinal Product 68 Clinical Trial Results 68 THELIN 68 Completes Enrollment 67 FDA Clears 67 Generic Version 67 Orphan Drug Status 67 Orphan Drug status 67 NOXAFIL 67 oropharyngeal candidiasis 67 Orphan Drug designation 67 Chronic Hepatitis C 67 Presents Positive 66 Ceftobiprole 66 Pirfenidone 66 Receives FDA Clearance 66 orphan designation 66 Pivotal Trial 66 Mutual Recognition Procedure 66 neovascular age 66 Pivotal Phase III 66 Patient Enrollment 65 human antithrombin 65 Gastric Cancer 65 Receives Patent 65 Blood Thinner 65 orphan medicinal product 65 FIRAZYR 65 Patients Treated 65 Patent Issued 65 Receives Approval 65 Irinotecan 64 Overactive Bladder 64 Marketing Authorization Application 64 Tacrolimus 64 Influenza Vaccine 64 FDA Approves 64 Metastatic Colorectal Cancer 64 Cetrorelix 64 Receives CE 64 submitted Marketing Authorization 64 Toctino R 64 Low Dose 64 R sorafenib tablets 64 Analgesics 64 Bird Flu Vaccine 64 Drug Eluting Stent 64 Receives Regulatory 64 Pulmonary Arterial Hypertension 64 Initiates Phase 64 Icatibant 64 Business Cycle Indicators 64 Cholesterol Drug 63 Gaucher Disease 63 diabetic peripheral neuropathic pain 63 Smallpox Vaccine 63 Chronic Heart Failure 63 Drug Resistant 63 Italy Latvia Lithuania 63 Cervical Cancer Vaccine 63 Diabetic Patients 63 Medicinal Products EMEA 63 Ranexa R 63 received CE Marking 63 Plenaxis R 63 Clevudine 63 Chronic Lymphocytic Leukemia 63 Reduces Risk 63 Monotherapy 63 Cancer Treatments 63 Combination Therapy 63 Receives Positive 63 Cancer Vaccine 63 Clinical Study 63 Lenalidomide 63 undergoing coronary angioplasty 63 FDA Orphan Drug 63 Oral Solution 63 FDA Clearance 63 Benign Prostatic Hyperplasia 63 Significantly Reduces 63 Surgical Adhesive 63 Well Tolerated 63 Monoclonal Antibody 62 Study Demonstrates 62 Angiox 62 Microspheres 62 Allergic Rhinitis 62 Toctino ® 62 Malaria Vaccine 62 Advanced Prostate Cancer 62 Adalimumab 62 Rifaximin

Back to home page